Citi Singapore receives dual award recognition from FinanceAsia and Forbes
Citi named Best International Bank and Best International Investment Bank in Singapore by FinanceAsia for the second year in a row Citi ranked as #1 in Singapore among Forbes World's Best Banks 2026 SINGAPORE, April 27, 2026 /PRNewswire/ -- Citi...
SK hynix receives 2026 IEEE Corporate Innovation Award for Driving AI Computing Expansion with HBM
SK hynix honored at the 2026 IEEE Awards for leading AI technology innovation with HBM Contributed to the global AI computing ecosystem via stable mass production across all HBM generations Company committed to becoming a premier leader in AI...
PRESIDENT SAMIA RECEIVES COMMISSION OF INQUIRY REPORT; CALLS FOR NATIONAL HEALING, ACCOUNTABILITY AND REFORMS
DAR ES SALAAM, Tanzania, April 24, 2026 /PRNewswire/ -- Her Excellency Dr. Samia Suluhu Hassan, President of the United Republic of Tanzania today received the Report of the Presidential Commission of Inquiry into the events of violence and breach...
4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union
In a separate announcement made today, the Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion. MELBOURNE, Australia, March 31, 2026 /PRNewswire/ -- 4DMedical Limited (ASX:4DX),...
Arnold Schwarzenegger receives Honorary Doctorate from Ulster University
Global screen icon, former Governor of California, Emmy-winning producer and seven-time Mr Olympia recognised for his contributions to public service, environmental action and the arts BELFAST, Northern Ireland , March 31, 2026 /PRNewswire/ --...
Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy
SHANGHAI, March 13, 2026 /PRNewswire/ -- On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the U.S....
XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult patients with multiple myeloma (MM). - In South Korea, XPOVIO® has been approved for three...
Cynosure Lutronic bolsters its strength in APAC -- The world's fastest-growing medical aesthetics device region, with dual regulatory approvals for the Clarity II™ in China and Japan, February 2026
SINGAPORE, Feb. 27, 2026 /PRNewswire/ -- Cynosure Lutronic, a global leader in energy-based medical aesthetic devices, announced today that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in China and...
DIFF Biotech's Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway
HANGZHOU, China, Feb. 9, 2026 /PRNewswire/ -- Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval as...
Insilico Medicine Receives USD 5million Milestone Payment from Menarini Group Following First-in-Human (FIH) Achievement for MEN2501
Followed by the development and regulatory milestone payment of USD 3 million in July 2025, Insilico received an additional milestone payment of USD 5 million from Menarini Group after first-in-patient dosing in a Phase 1 trial of MEN2501, highly...